|
Vector Laboratories
lca conjugated agarose beads  Lca Conjugated Agarose Beads, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lca conjugated agarose beads/product/Vector Laboratories Average 92 stars, based on 1 article reviews
lca conjugated agarose beads - by Bioz Stars,
2026-03
92/100 stars
|
Buy from Supplier |
|
Seikagaku corporation
lectin agarose wga Lectin Agarose Wga, supplied by Seikagaku corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/lectin agarose wga/product/Seikagaku corporation Average 90 stars, based on 1 article reviews
lectin agarose wga - by Bioz Stars,
2026-03
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Cancer
Article Title: Identification of LCA-binding Glycans as a Novel Biomarker for Esophageal Cancer Metastasis using a Lectin Array-based Strategy
doi: 10.7150/jca.43806
Figure Lengend Snippet: Effects of LCA on EC cell migration and invasion. (A) Representative images and the mean migration number for each treatment group. (B) Representative images and the mean invasion number for each treatment group. (C) Cell viability for each treatment group. (D) Expression levels of the MMPs and PI3K/Akt pathway-associated proteins for cells treated with LCA at the IC50 concentration. Untreated cells served as a control. * P < 0.05 compared to the control group.
Article Snippet: To capture the glycoproteins, proteins from whole-cell extractions were incubated with
Techniques: Migration, Expressing, Concentration Assay
Journal: Journal of Cancer
Article Title: Identification of LCA-binding Glycans as a Novel Biomarker for Esophageal Cancer Metastasis using a Lectin Array-based Strategy
doi: 10.7150/jca.43806
Figure Lengend Snippet: Effects of tunicamycin on EC cell migration and invasion. (A) Cell viability for each treatment group. (B) Representative images and the mean migration number for cells treated with tunicamycin at the IC50 concentration. (C) Representative images and the mean invasion number for cells treated with tunicamycin at the IC50 concentration. (D) Expression levels of LCA-binding glycans for cells treated with tunicamycin at the IC50 concentration. (E) Expression levels of the MMPs and PI3K/Akt pathway-associated proteins for cells treated with tunicamycin at the IC50 concentration. Cells treated with DMSO served as a control. * P < 0.05 compared to the control group.
Article Snippet: To capture the glycoproteins, proteins from whole-cell extractions were incubated with
Techniques: Migration, Concentration Assay, Expressing, Binding Assay
Journal: Journal of Cancer
Article Title: Identification of LCA-binding Glycans as a Novel Biomarker for Esophageal Cancer Metastasis using a Lectin Array-based Strategy
doi: 10.7150/jca.43806
Figure Lengend Snippet: Identification of CD147 as an LCA-recognized glycoprotein. (A) Coomassie blue staining for immunoprecipitated samples. (B) LCA immunoprecipitation assay for Eca-109 and KYSE-150 cells. PD: pull down. (C) Representative photomicrographs for CD147 expression in EC and adjacent non-tumor tissues. Scale bar represents 100 µm. (D) Analysis of CD147 expression based on the scoring data for IHC (E) Correlation between LCA-binding glycans and CD147 expression in EC tissues. IgG served as a control. P < 0.05.
Article Snippet: To capture the glycoproteins, proteins from whole-cell extractions were incubated with
Techniques: Staining, Immunoprecipitation, Expressing, Binding Assay